Michelle Fullard, MD
Enriched profileAssociate Professor of Neurology; Director of Research, Movement Disorders Center · University of Colorado Anschutz Medical Campus
Michelle Fullard is Associate Professor of Neurology; Director of Research, Movement Disorders Center at University of Colorado Anschutz Medical Campus. OpenAlex indexes 53 publications with 1,476 citations (h-index 18); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 11 Oct 2026
Overview
Updated 18 Oct 2026
Michelle Fullard, MD, is Associate Professor of Neurology at University of Colorado Anschutz Medical Campus. The public record shows 53 publications with 1,476 citations (h-index 18), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Dementia and Cognitive Impairment Research. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 3 companies, 1 NIH-funded awards (2024–2026).
- Most recent indexed publication: 2026 · Journal of Parkinson's disease
- Top research focus: Parkinson's Disease Mechanisms and Treatments
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 22.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Evaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease
Sponsor: University of Colorado, Denver
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Industry payments
Updated 18 Oct 2026
3 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- Neurocrine Biosciences, Inc.Program year20241 payment
- Abbott LaboratoriesProgram year20221 payment
- Sunovion Pharmaceuticals Inc.Program year20213 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
94.8%Aromatic Amino Acid Decarboxylation Inhibitor53.6%Carbidopa-Levodopa52%Carbidopa-Levodopa Er31%Rytary17%Part D≥56 patientsInfluenza A M2 Protein Inhibitor7.4%Amantadine67%Gocovri33%Part D<11 patients+ 8 more classes in this area
Cardiovascular
5.2%alpha-Adrenergic Agonist3.3%Midodrine Hcl100%Part D<11 patientsBeta blocker1.9%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Improving Shared Decision-Making for Older Adults with Cognitive Impairment: Parkinson's Disease as a Model
University of Colorado Denver
FY2026$242,779K76AG083349 - Improving Shared Decision-Making for Older Adults with Cognitive Impairment: Parkinson's Disease as a Model
University of Colorado Denver
FY2025$242,716K76AG083349 - Improving Shared Decision-Making for Older Adults with Cognitive Impairment: Parkinson's Disease as a Model
University of Colorado Denver
FY2024$242,956K76AG083349
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Development and acceptability of a deep brain stimulation surgery decision aid for Parkinson's disease.
Journal of Parkinson's disease
Article2026 - Early-Onset Parkinson's Disease: Unique Features and Management Approaches.
Current neurology and neuroscience reports
Review2025
Most-cited works
by citation count (OpenAlex)- 01Olfactory Dysfunction as an Early Biomarker in Parkinson’s DiseaseArticle323 citations2017
- 02Olfactory impairment predicts cognitive decline in early Parkinson's diseaseArticle120 citations2016
- 03
- 04A Review of the Relationship Between Vitamin D and Parkinson Disease SymptomsArticle100 citations2020
- 05Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD studyArticle96 citations2023
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/michelle-fullard-md-4e1e890c
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Secondary affiliations
appointments beyond the home institution- Director
Parkinson Foundation Center of Excellence, University of Colorado
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →apdaparkinson.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
Satish Garg, MD
University of Colorado Anschutz Medical Campus
Michel Chonchol, MD
University of Colorado Anschutz Medical Campus
Jeffrey Bennett, MD
University of Colorado Anschutz Medical Campus
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health